Head and Neck TumorsHead and Neck TumorsОпухоли головы и шеи2222-14682411-4634Publishing House ABV Press24010.17650/2222-1468-2017-7-1-81-85ORIGINAL REPORTSОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯEyelid skin cancer: еpidemiology, prognosisРак кожи век: эпидемиология, прогнозBrovkinaA. F.БровкинаА. Ф.
Russian Federation

2/1 Barrikadnaya St., Moscow, 125993, Russia

Россия, 125993 Москва, ул. Баррикадная, 2/1

anab@list.ruLernerM. Yu.ЛернерМ. Ю.
Russian Federation

7 Mamonovskiy Lane, Moscow 123001, Russia

Россия,123001 Мамоновский пер., 7

Russian Medical Academy of Continuous Professional Education at the Ministry of Health of RussiaФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииBranch № 1 “Ophthalmology Clinic” of the S.P. Botkin City Clinical Hospital of the Moscow Healthcare DepartmentФилиал № 1 «Офтальмологическая клиника» ГБУЗ г. Москвы «Городская клиническая больница им. С.П. Боткина Департамента здравоохранения г. Москвы»020420177181850204201702042017Copyright ©; 2017, Brovkina A.F., Lerner M.Y.Copyright ©; 2017, Бровкина А.Ф., Лернер М.Ю.2017Brovkina A.F., Lerner M.Y.Бровкина А.Ф., Лернер М.Ю.https://creativecommons.org/licenses/by/4.0https://ogsh.abvpress.ru/jour/article/view/240

Data on 3597 patients with primary malignant tumors of the visual organ were submitted to the Moscow City Cancer Register of the Moscow Healthcare Department in 2006–2015. Rate of eyelid skin cancer is 75.62 %. Calculated incidence is 3.4 per 100,000 population. The peak of the disease is at 70–80 years of age. The disease was diagnosed in people of age 46–85 years, it was 66.65 % more frequent in women than in men. Basal cell carcinoma comprised 91.14 % of all cases. In 65.7 % of cases the tumor was diagnosed at stage Т1 and Т2, and at stage Т1, when patient can be cured, only in 34 % of cases. 

Objective. Study of incidence of malignant eyelid tumors of epithelial genesis, their prognostic characteristics using data from Moscow City Ophthalmic Oncology Center and Ophthalmic Oncology Department of the Branch # 1 “Ophthalmology Clinic” of the S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department.

В Московский городской канцер-регистр Департамента здравоохранения города Москвы за 2006–2015 гг. внесены сведения о 3597 больных с первично выявленными злокачественными опухолями органа зрения. Частота рака кожи век среди них составила 75,62 %. Расчетная встречаемость составила 3,4 на 100 тыс. населения. Пик заболевания – 7–8-я декады жизни. Заболевают лица в возрасте 46–85 лет, женщины на 66,65 % чаще мужчин. Базально-клеточный рак составил 91,14 %. В 65,7 % случаев опухоль первично выявлена в стадии Т1 и Т2, а в стадии Т1, когда больной может быть полностью излечен от опухоли, – всего в 34 %.

Цель исследования – изучение частоты встречаемости злокачественных опухолей век эпителиального генеза, их прогностических особенностей по материалам Московского городского офтальмоонкологического центра и офтальмоонкологического отделения филиала № 1 «Офтальмологическая клиника» ГБУЗ г. Москвы «ГКБ им. С. П. Боткина Департамента здравоохранения г. Москвы».

basal cell carcinomaeyelid skin carcinomamalignant eyelid tumors of epithelial genesisadenocarcinomaбазально-клеточный рак кожикожные карциномы векзлокачественные опухоли век эпителиального генезааденокарцинома1. Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146:1–6. PMID: 11966724Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146:1–6. PMID: 119667242. Панова И.Е., Важенин А.В., Усова Р.А. и др. Эпидемиология, клинико-морфологическая характеристика, дифференциальная диагностика базально-клеточного рака кожи век. Челябинск, 2003. 14 с. [Panova I.E., Vazhenin A.V., Usova R.A. et al. Epidemiology, clinical and morphological characteristics, differential diagnosis of eyelid skin basal cell carcinoma. Chelyabinsk, 2003. 14 p. (In Russ.)].Панова И.Е., Важенин А.В., Усова Р.А. и др. Эпидемиология, клинико-морфологическая характеристика, дифференциальная диагностика базально-клеточного рака кожи век. Челябинск, 2003. 14 с. [Panova I.E., Vazhenin A.V., Usova R.A. et al. Epidemiology, clinical and morphological characteristics, differential diagnosis of eyelid skin basal cell carcinoma. Chelyabinsk, 2003. 14 p. (In Russ.)].3. Cook B.E. Jr, Bartley G.B. Treatment options and future prospects for the management of eyelid malignancies: An evidencebased update. Ophthalmology 2001;108:2088–98. PMID: 11713084Cook B.E. Jr, Bartley G.B. Treatment options and future prospects for the management of eyelid malignancies: An evidencebased update. Ophthalmology 2001;108:2088–98. PMID: 117130844. Murchison A.P., Walrath J.D., Washington C.V. Non-surgical treatments of primary, nonmelanoma eyelid malignancies: a review. Clin Exp Ophthalmol 2011;39:65–83. DOI: 10.1111/j.1442-9071.2010.02422.x. PMID: 21040309Murchison A.P., Walrath J.D., Washington C.V. Non-surgical treatments of primary, nonmelanoma eyelid malignancies: a review. Clin Exp Ophthalmol 2011;39:65–83. DOI: 10.1111/j.1442-9071.2010.02422.x. PMID: 210403095. Actis A.G., Actis G., De Sanctis U. et al. Eyelid benign and malignant tumors: issues in classification, excision and reconstruction. Minerva Chir 2013;68:(Suppl.1)11–25. PMID: 24172760Actis A.G., Actis G., De Sanctis U. et al. Eyelid benign and malignant tumors: issues in classification, excision and reconstruction. Minerva Chir 2013;68:(Suppl.1)11–25. PMID: 241727606. Marzuka A.G., Book S.E. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and mana gement eyelid masses: A 10-year survey from a tertiary eye hospital in Tehran. Middle East Afr J Ophthalmol 2013;20:3:187–92. DOI: 10.4103/0974-9233.114788.Marzuka A.G., Book S.E. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and mana gement eyelid masses: A 10-year survey from a tertiary eye hospital in Tehran. Middle East Afr J Ophthalmol 2013;20:3:187–92. DOI: 10.4103/0974-9233.114788.7. ICD-O Международная классификация онкологических болезней. 2000. С. 184. [International classification of oncological diseases ICD-O. 2000. P. 184. (In Russ.)].ICD-O Международная классификация онкологических болезней. 2000. С. 184. [International classification of oncological diseases ICD-O. 2000. P. 184. (In Russ.)].8. Allali J., D’Hermies F., Renard G. Basal cell carcinomas of the eyelids. Ophthalmologica 2005;219:57–71. DOI: 10.1159/000083263. PMID: 15802929Allali J., D’Hermies F., Renard G. Basal cell carcinomas of the eyelids. Ophthalmologica 2005;219:57–71. DOI: 10.1159/000083263. PMID: 158029299. Faustina M., Diba R., Ahmadi M.A. et al. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology 2004;111: 1930–2. DOI: 10.1016/j.ophtha.2004.02.009. PMID: 5465559Faustina M., Diba R., Ahmadi M.A. et al. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology 2004;111: 1930–2. DOI: 10.1016/j.ophtha.2004.02.009. PMID: 546555910. Lin H.Y., Cheng C.Y., Hsu W.M. et al. Incidence of eyelid cancers in Taiwan: A 21-year review. Ophthalmology 2006;113:2101–7. DOI: 10.1016/j.ophtha.2006.06.001. PMID: 16962174Lin H.Y., Cheng C.Y., Hsu W.M. et al. Incidence of eyelid cancers in Taiwan: A 21-year review. Ophthalmology 2006;113:2101–7. DOI: 10.1016/j.ophtha.2006.06.001. PMID: 1696217411. Weinstock M.A., Still J.M. Assessing current treatment options for patients with severe/ advanced basal cell carcinoma. Semin Cutan Med Surg 2011;30(4 Suppl):10–3. DOI: 10.1016/j.sder.2011.11.004. PMID 22177101Weinstock M.A., Still J.M. Assessing current treatment options for patients with severe/ advanced basal cell carcinoma. Semin Cutan Med Surg 2011;30(4 Suppl):10–3. DOI: 10.1016/j.sder.2011.11.004. PMID 2217710112. Asproudis I., Sotiropoulos G., Gartzios Ch. et al. Eyelid tumors at the University Eye Clinic of Ioannina, Greece: A 30-year Retrospective Study. Middle East Afr J Ophthalmol 2015;22:2:230–2. DOI: 10.4103/0974-9233.151881PMCID:PMC4411622. PMID: 25949083Asproudis I., Sotiropoulos G., Gartzios Ch. et al. Eyelid tumors at the University Eye Clinic of Ioannina, Greece: A 30-year Retrospective Study. Middle East Afr J Ophthalmol 2015;22:2:230–2. DOI: 10.4103/0974-9233.151881PMCID:PMC4411622. PMID: 2594908313. Bagheri А., Tavakoli M., Kanaani A. et al. Eyelid masses: A 10-year survey from a tertiary eye hospital in Tehran. Middle East Afr J Ophthalmol 2013;20:187–92. DOI: 10.4103/0974- 9233.114788. PMID: 24014978Bagheri А., Tavakoli M., Kanaani A. et al. Eyelid masses: A 10-year survey from a tertiary eye hospital in Tehran. Middle East Afr J Ophthalmol 2013;20:187–92. DOI: 10.4103/0974- 9233.114788. PMID: 2401497814. Domingo R.E., Manganip L.E., Castro R.M. Tumors of the eye and ocular adnexa at the Philippine Eye Research Institute: a 10-year review. Clin Ophthalmol 2015;9:1239–47. DOI: 10.2147/OPTH.S87308.Collection.2015. PMID: 26185414Domingo R.E., Manganip L.E., Castro R.M. Tumors of the eye and ocular adnexa at the Philippine Eye Research Institute: a 10-year review. Clin Ophthalmol 2015;9:1239–47. DOI: 10.2147/OPTH.S87308.Collection.2015. PMID: 2618541415. Huang Y.Y., Liang W.Y., Tsai C.C. et al. Comparison of the clinical haracteristics and outcome of benign and malignant eyelid tumors: an analysis of 4521 eyelid tumors in a Tertiary Medical Center. Biomed Res Int 2015:453091. DOI:10.1155/2015/453091. PMID: 26634208Huang Y.Y., Liang W.Y., Tsai C.C. et al. Comparison of the clinical haracteristics and outcome of benign and malignant eyelid tumors: an analysis of 4521 eyelid tumors in a Tertiary Medical Center. Biomed Res Int 2015:453091. DOI:10.1155/2015/453091. PMID: 2663420816. Samarasinghe V., Madan V. Nonmelanoma skin cancer. J Cutan Aesthet Surg 2012;5: 3– 10. DOI: 10.4103/0974-2077.94323. PMID: 22557848Samarasinghe V., Madan V. Nonmelanoma skin cancer. J Cutan Aesthet Surg 2012;5: 3– 10. DOI: 10.4103/0974-2077.94323. PMID: 2255784817. Sekulic A., Migden M.R., Basset-Seguin N. et al. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study. J Clin Oncol 2013;31 (suppl; abstr 9037).Sekulic A., Migden M.R., Basset-Seguin N. et al. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study. J Clin Oncol 2013;31 (suppl; abstr 9037).18. Suzuki H.S., Serafini S.Z., Sato M.S. Utility of dermoscopy for demarcation of surgical margins in Mohs micrographic surgery. An Bras Dermatol 2014;8:38–43. DOI: 10.1590/abd1806-4841.20142400. PMCID: PMC3938352Suzuki H.S., Serafini S.Z., Sato M.S. Utility of dermoscopy for demarcation of surgical margins in Mohs micrographic surgery. An Bras Dermatol 2014;8:38–43. DOI: 10.1590/abd1806-4841.20142400. PMCID: PMC393835219. Takamura H., Yamashita H. Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol 2005;49(5):349–54. DOI: 10.1007/s10384-005-0229-5. PMID:16187033Takamura H., Yamashita H. Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol 2005;49(5):349–54. DOI: 10.1007/s10384-005-0229-5. PMID:1618703320. Rene C. Oculoplastic aspects of ocular oncology. Eye (Lond) 2013;27:199–207. DOI: 10.1038/eye.2012.24. PMID: 23196649Rene C. Oculoplastic aspects of ocular oncology. Eye (Lond) 2013;27:199–207. DOI: 10.1038/eye.2012.24. PMID: 2319664921. Kale S.M., Patil S.B., Khare N. et al. Clinicopathological analysis of eyelid malignancies – A review of 85 cases. Indian J Plast Surg 2012;45(1):22–8. DOI: 10.4103/0970-0358.96572. PMCID: PMC3385393Kale S.M., Patil S.B., Khare N. et al. Clinicopathological analysis of eyelid malignancies – A review of 85 cases. Indian J Plast Surg 2012;45(1):22–8. DOI: 10.4103/0970-0358.96572. PMCID: PMC3385393